The French National Research Agency, in partnership with 18 countries is launching a 8th joint transnational call for proposals through the ERA-NET EuroNanoMed (ENM) on Nanomedicine.
The goal of this call for proposals is to both support translational research projects that combine innovative approaches in the field of Nanomedicine and to encourage and enable transnational collaboration between public and private research groups from academia, clinical/public health research or research teams from industrial enterprises (all sizes). The participation of Medical Doctors and SMEs will be strongly encouraged. This call for proposals includes funding research organisations of 19 countries (Belgium, Canada, Estonia, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Romania, Slovakia, Spain, Taiwan, and Turkey) and should be allowed of global budget of M€14.
Project proposals will need to cover at least one of the following areas that are equal in relevance for this call: regenerative medicine, diagnostics, targeted delivery systems.
The projects should fall within Technology Readiness Levels (TRL) 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.
A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories:
Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call. The project coordinator must be eligible to be funded by EuroNanoMed III participating countries/regions. No more than 2 eligible partners from the same country participating in the call will be accepted in one consortium. Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding can be included.
The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, which are either new in the EuroNanoMed consortium or their community has been under-represented in past EuroNanoMed calls: Belgium, Estonia, Ireland, Latvia, Lithuania, Romania, Slovakia, Taiwan, and Turkey (see table below).
|Number of partners requesting funding (eligible partners)||3||4||5||6 |
(only with at least one underrepresented/new)
(only with at least 2 underrepresented/new)
|Possible number of additional partners with own funding||1||1||1||1||0|
The specific annex for French partners is available on this site. The call text, proposal template, and guidelines for applicants are available on this site or on www.euronanomed.net.
Research project consortia who intend to submit a transnational proposal should register as soon as possible, at https://secure.pt-dlr.de/ptoutline/app/euronanomed2017, by clicking on “to register” and following instructions.
Electronic proposal submission of proposals on the indicated website is mandatory. No proposal submissions will be accepted directly at ANR.
Contact person for the Joint Call Secretariat:
ENMCalls(at)anr.fr ; +33 (0)1 78 09 80 44
Dr. Amélie Vergne
The appelsprojetsrecherche.fr portal centralises all information on calls for proposals and calls for applications from ADEME, ANR, Inserm including ANRS, Anses and INCa. It provides a simplified access to upcoming and ongoing calls, giving a greater visibility to funding opportunities. Following their closing date, the calls remain published for a few months.